GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Guangdong Bawei Biotechnology Corp (BJSE:837023) » Definitions » Total Assets

Guangdong Bawei Biotechnology (BJSE:837023) Total Assets : ¥792.5 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Guangdong Bawei Biotechnology Total Assets?

Guangdong Bawei Biotechnology's Total Assets for the quarter that ended in Sep. 2024 was ¥792.5 Mil.

During the past 12 months, Guangdong Bawei Biotechnology's average Total Assets Growth Rate was 32.40% per year. During the past 3 years, the average Total Assets Growth Rate was 25.60% per year. During the past 5 years, the average Total Assets Growth Rate was 44.40% per year. During the past 10 years, the average Total Assets Growth Rate was 59.20% per year.

During the past 11 years, Guangdong Bawei Biotechnology's highest 3-Year average Total Assets Growth Rate was 134.20%. The lowest was 25.60%. And the median was 49.30%.

Total Assets is connected with ROA %. Guangdong Bawei Biotechnology's annualized ROA % for the quarter that ended in Sep. 2024 was 7.59%. Total Assets is also linked to Revenue through Asset Turnover. Guangdong Bawei Biotechnology's Asset Turnover for the quarter that ended in Sep. 2024 was 0.27.

Guangdong Bawei Biotechnology Total Assets Historical Data

The historical data trend for Guangdong Bawei Biotechnology's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Bawei Biotechnology Total Assets Chart

Guangdong Bawei Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 234.47 382.61 617.02 623.58 663.18

Guangdong Bawei Biotechnology Quarterly Data
Mar18 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 601.36 663.18 678.93 716.78 792.54

Guangdong Bawei Biotechnology Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Guangdong Bawei Biotechnology's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=330.189+332.993
=663.2

Guangdong Bawei Biotechnology's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=386.072+406.467
=792.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangdong Bawei Biotechnology  (BJSE:837023) Total Assets Explanation

Total Assets is connected with ROA %.

Guangdong Bawei Biotechnology's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=57.244/( (716.779+792.539)/ 2 )
=57.244/754.659
=7.59 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Guangdong Bawei Biotechnology's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=205.067/( (716.779+792.539)/ 2 )
=205.067/754.659
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Guangdong Bawei Biotechnology Total Assets Related Terms

Thank you for viewing the detailed overview of Guangdong Bawei Biotechnology's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong Bawei Biotechnology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Guangdong Bawei Biotechnology Corp (BJSE:837023) » Definitions » Total Assets
Comparable Companies
Traded in Other Exchanges
N/A
Address
Xinbei Road, No. 5, Baiyun District, Guangdong Province, Guangzhou, CHN, 510450
Website
http://www.gzbawei.com
Guangdong Bawei Biotechnology Corp is engaged in product planning, formula research and development, manufacturing, and efficacy testing of cosmetics.

Guangdong Bawei Biotechnology Headlines

No Headlines